ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Genome Therapeutics Ltd

Genome Therapeutics Ltd is an active company incorporated on 8 January 2020 with the registered office located in London, Greater London. Genome Therapeutics Ltd was registered 6 years ago.
Status
Active
Active since incorporation
Company No
12392992
Private limited company
Age
6 years
Incorporated 8 January 2020
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Due Soon
Dated 7 January 2025 (1 year ago)
Next confirmation dated 7 January 2026
Due by 21 January 2026 (13 days remaining)
Last change occurred 12 months ago
Accounts
Submitted
For period 1 Jul30 Jun 2025 (12 months)
Accounts type is Small
Next accounts for period 30 June 2026
Due by 31 March 2027 (1 year 2 months remaining)
Contact
Address
Regent House
316 Beulah Hill
London
SE19 3HF
United Kingdom
Same address since incorporation
Telephone
Unreported
Email
Unreported
People
Officers
5
Shareholders
8
Controllers (PSC)
1
Director • Ceo • American • Lives in England • Born in Dec 1967
Director • Investor • Lives in UK • Born in May 1966
Director • None • Canadian • Lives in Canada • Born in Oct 1963
Director • Investor • American • Lives in United States • Born in Mar 1992
Director • British • Lives in UK • Born in Oct 1970
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Faculty Science Limited
Saul Charles Klein is a mutual person.
Active
Zinc Ventures Limited
Saul Charles Klein is a mutual person.
Active
Phoenix Court Spaces Limited
Saul Charles Klein is a mutual person.
Active
Phoenix Court Group Limited
Saul Charles Klein is a mutual person.
Active
The Manchester Academy Ltd
Saul Charles Klein is a mutual person.
Active
Phoenix Court Works Limited
Saul Charles Klein is a mutual person.
Active
Newton Venture Education Limited
Saul Charles Klein is a mutual person.
Active
The Next Economy Works Limited
Saul Charles Klein is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2021–2025)
Period Ended
30 Jun 2025
For period 30 Jun30 Jun 2025
Traded for 12 months
Cash in Bank
£362.94K
Decreased by £1.11M (-75%)
Turnover
Unreported
Same as previous period
Employees
6
Same as previous period
Total Assets
£642.86K
Decreased by £1.39M (-68%)
Total Liabilities
-£278.02K
Decreased by £44.45K (-14%)
Net Assets
£364.84K
Decreased by £1.34M (-79%)
Debt Ratio (%)
43%
Increased by 27.36% (+172%)
Latest Activity
Dr James Walter Glasheen Appointed
2 Months Ago on 20 Oct 2025
Notification of PSC Statement
2 Months Ago on 16 Oct 2025
Small Accounts Submitted
3 Months Ago on 6 Oct 2025
Dr Samuel Aparicio Appointed
3 Months Ago on 14 Sep 2025
Shankar Balasubramanian Resigned
3 Months Ago on 14 Sep 2025
Samuel Aparicio (PSC) Resigned
5 Months Ago on 8 Aug 2025
Shankar Balasubramanian (PSC) Resigned
5 Months Ago on 8 Aug 2025
Mr Saul Charles Klein Appointed
5 Months Ago on 8 Aug 2025
Shares Cancelled
11 Months Ago on 5 Feb 2025
Own Shares Purchased
11 Months Ago on 4 Feb 2025
Get Credit Report
Discover Genome Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Resolutions
Submitted on 18 Dec 2025
Memorandum and Articles of Association
Submitted on 18 Dec 2025
Statement of capital following an allotment of shares on 26 November 2025
Submitted on 11 Dec 2025
Resolutions
Submitted on 28 Oct 2025
Appointment of Dr James Walter Glasheen as a director on 20 October 2025
Submitted on 27 Oct 2025
Statement of capital following an allotment of shares on 20 October 2025
Submitted on 25 Oct 2025
Notification of a person with significant control statement
Submitted on 16 Oct 2025
Appointment of Dr Samuel Aparicio as a director on 14 September 2025
Submitted on 8 Oct 2025
Termination of appointment of Shankar Balasubramanian as a director on 14 September 2025
Submitted on 7 Oct 2025
Accounts for a small company made up to 30 June 2025
Submitted on 6 Oct 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year